Macroview Investment Management’s AstraZeneca AZN Stock Holding History

Macroview Investment Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-44	Closed	-$5.96K	–	638
2023 Q3	$5.96K	Buy	+44	New	+$6.01K	0.01%	391
2020 Q2	–	Sell	-32	Closed	-$3K	–	315
2020 Q1	$3K	Hold	32	–	–	0.01%	166
2019 Q4	$3K	Hold	32	–	–	0.01%	226
2019 Q3	$3K	Hold	32	–	–	0.01%	220
2019 Q2	$3K	Hold	32	–	–	0.01%	226
2019 Q1	$3K	Hold	32	–	–	0.01%	228
2018 Q4	$2K	Hold	32	–	–	0.01%	253
2018 Q3	$2K	Buy	+32	New	+$2.42K	0.01%	270
2015 Q1	–	Sell	-16	Closed	-$1K	–	141
2014 Q4	$1K	Hold	16	–	–	﹤0.01%	147
2014 Q3	$1K	Buy	+16	New	+$1.17K	﹤0.01%	157

Other funds holding AZN

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sanders Capital

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return